---
document_datetime: 2023-09-21 17:11:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/pravafenix-epar-all-authorised-presentations_en.pdf
document_name: pravafenix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1518513
conversion_datetime: 2025-12-20 13:27:38.147385
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|--------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/11/679/001  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | blister (alu/alu)     | 30 capsules |
| EU/1/11/679/002  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | blister (alu/alu)     | 60 capsules |
| EU/1/11/679/003  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | blister (alu/alu)     | 90 capsules |
| EU/1/11/679/004  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | bottle (HDPE)         | 30 capsules |
| EU/1/11/679/005  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | bottle (HDPE)         | 60 capsules |
| EU/1/11/679/006  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | bottle (HDPE)         | 90 capsules |
| EU/1/11/679/007  | Pravafenix        | 40 mg/160 mg | Capsule, hard         | Oral use                  | bottle (HDPE)         | 14 capsules |